Comparison of Rimegepant and Placebo for Pain in IBS | MicrobiomeTrials← Back to trialsNCT06221111
Comparison of Rimegepant and Placebo for Pain in IBS
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2024-06-06Est. Completion: 2025-05-30
Enrollment target: 39 participants Locations- Mayo Clinic in Rochester, Rochester, Minnesota, United States
Other microbiome trials you might be interested in
Functional Gastrointestinal Disorders (FGID)
Brief Summary
Functional gastrointestinal disorders (FGID), including irritable bowel syndrome (IBS), are common condit…
Multiple LocationsEst. completion Sep 1, 2027
Irritable Bowel Syndrome (IBS)
To explore the efficacy of pregabalin for patients with irritable bowel syndrome (IBS).
Beijing, ChinaEst. completion Apr 8, 2026
Ulcerative Colitis
Healthy
Irritable Bowel Syndrome With Diarrhea
This trial is being completed to learn about how Aquamin® affects gastrointestinal permeability, or the control of mater…
Ann Arbor, United StatesCompleted Mar 11, 2024